Pay in 4 interest-free payments of $5.16 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Anticipate additional randomized trials comparing peptide combinations to standard care and investigations into long-term safety
Tesamorelin is a synthetic 44-amino-acid polypeptide analogue of Growth Hormone-Releasing Hormone (GHRH) 1 with modifications to improve stability and pharmacokinetics compared to native GHRH
This protocol is designed as a "peptide burst" a short, potent intervention that minimizes the risk of receptor downregulation and insulin resistance while maximizing anabolic response
Published Research Context Research on Ipamorelin referenced in clinical literature includes animal studies demonstrating GH release stimulation, limited human pharmacokinetic studies establishing dosing parameters, and research examining Ipamorelin's effects on gastrointestinal motility, where it has shown particular interest for post-operative applications
